24/7 Patient Assistance: 760-405-8205

Nihal Abdulla, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Nihal Abdulla is a medical oncology specialist in Los Alamitos, California and he works at several hospitals in the area, including DeTar Hospital Navarro and College Station Medical Center. He got his diploma from Dow University of Health Sciences and did his residency in Internal Medicine at University of Texas Medical Branch Hospitals, where he also completed a fellowship in Medical Oncology. The doctor is certified in Internal Medicine and Medical Oncology and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Dow University of Health Sciences

    Medical School

    dept_icon

    University of Texas Medical Branch Hospitals

    Residency

    dept_icon

    University of Texas Medical Branch Hospitals

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    College Station Medical Center

    Languages: English/Spanish

    (979) 764-5100

    1604 Rock Prairie Rd

    College Station, Texas 77845

    Read More

    University of Texas Medical Branch

    Languages: English/Spanish

    (409) 772-1011

    301 University Blvd

    Galveston, Texas 77555

    Read More
  • Publications & Memberships

    Dr. Nihal Abdulla has contributed to 3 publications.

    In situ hybridization for the detection of hepatitis C virus RNA in human liver tissue.

    Li, G.,Li, K.,Lea, A. S.,Li, N. L.,Abdulla, N. E.,Eltorky, M. A.,Ferguson, M. R.; J Viral Hepat. 2013 Mar.

    See more >>

    Hyalinizing clear cell carcinoma of the tonsil and its treatment.

    Hijjawi, S. B., Abdullah, S. E., Abdelhadi, K., Eyzaguirre, E., Willis, M., Abdulla, N. E.; Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Aug.

    See more >>

    Rituximab: current status as therapy for malignant and benign hematologic disorders.

    Abdulla, N. E.,Ninan, M. J.,Markowitz, A. B.; BioDrugs. 2012 Feb 22.

    See more >>